Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Regeneron Pharmaceuticals Inc : Regeneron Pharmaceuticals Assigned Patent

12/31/2013 | 03:06am US/Eastern
Recommend:
0

By Targeted News Service

ALEXANDRIA, Va., Dec. 31 -- Regeneron Pharmaceuticals, Tarrytown, N.Y., has been assigned a patent (8,613,927) developed by five co-inventors for a "high affinity human antibodies to human nerve growth factor." The co-inventors are Lynn MacDonald, White Plains, N.Y., Richard Torres, New York, Marc R. Morra, Beacon Falls, Conn., Joel H. Martin, Putnam Valley, N.Y., and Joel C. Reinhardt, Mount Kisco, N.Y.

The patent application was filed on Feb. 28, 2012 (13/406,734). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=3&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=141&f=G&l=50&co1=AND&d=PTXT&s1=20131224.PD.&s2=%28NY.ASST.%29&OS=ISD/12/24/2013+AND+AS/NY&RS=ISD/12/24/2013+AND+AS/NY

Written by Sudarshan Harpal; edited by Jaya Anand.

SH1231JA1231-963857

© Targeted News Service, Acquiremedia 2014
Recommend :
0
React to this article
Latest news on REGENERON PHARMACEUTICALS
1d ago REGENERON PHARMACEUTICALS : Patent Application Titled "Readily Isolated Bispecif..
2d ago REGENERON PHARMACEUTICALS : EYLEA® (aflibercept) Injection Receives FDA Breakthr..
09/10 REGENERON PHARMACEUTICALS : Announces Submission of Application for EYLEA® aflib..
09/10 REGENERON PHARMACEUTICALS : Patent Application Titled "Genetically Modified Majo..
09/09 REGENERON PHARMACEUTICALS : Biotech Stocks Under Review -- Keryx Biopharma, Sang..
09/08 NASDAQ 100 MOVERS : Regn, yhoo
09/07 REGENERON PHARMACEUTICALS : and Sanofi Updates on Positive Results from 4 Aliroc..
09/04 REGENERON PHARMACEUTICALS : Patent Issued for Conditioned Culture Media
09/04 NASDAQ 100 MOVERS : Spls, fast
09/04 REGENERON PHARMACEUTICALS : Announces Submission of Application for EYLEA® (afli..
Advertisement
Chart
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Income Statement Evolution
Regeneron Pharmaceuticals  : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF